This is because intensive insulin therapy not only controls elevated glucose levels in the critically ill, but has been shown to significantly improve outcomes among hospital in patients with acute hyperglycaemia or newly diagnosed diabetes. This evidence concerns the gene INS and diabetes mellitus.